FAKTOR-OPTIONSSCHEIN - MEDTRONIC Share Price

Certificat

DE000SD41858

Market Closed - Boerse Frankfurt Warrants 20:49:14 28/06/2024 BST
12.34 EUR +0.08% Intraday chart for FAKTOR-OPTIONSSCHEIN - MEDTRONIC
Current month+5.09%
1 month+7.97%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/06/24 12.19 -1.14%
27/06/24 12.33 +1.65%
26/06/24 12.13 +1.00%
25/06/24 12.01 +1.78%
24/06/24 11.8 +1.29%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 08:49 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SD4185
ISINDE000SD41858
Date issued 29/03/2021
Strike 116.7 $
Maturity Unlimited
Parity 1 : 1
Emission price 8.49
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 16.96
Lowest since issue 6.06
Spread 0.01
Spread %0.08%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.71 USD
Average target price
94.02 USD
Spread / Average Target
+19.46%
Consensus